References
- JohnsonLBoonJOrtonECClinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992–1996J Vet Intern Med199913544044710499728
- KellihanHStepienRPulmonary hypertension in dogs: diagnosis and therapyVet Clin North Am Small Anim Pract201040462364120610015
- BachJFRozanskiEAMacGregorJBetkowskiJMRushJERetrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogsJ Vet Intern Med20062051132113517063705
- ForfiaPRobertsJDiagnosis and assessment of pulmonary vascular disease by Doppler echocardiographyPulm Circ20111216022034604
- KellumHBStepienRLSildenafil citrate therapy in 22 dogs with pulmonary hypertensionJ Vet Intern Med20072161258126418196735
- KellihanHStepienRLPulmonary hypertension in canine degenerative mitral valve diseaseJ Vet Cardiol201214114916422364721
- StepienRLPulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogsJ Small Anim Pract200950344319765218
- ToyoshimaYKanemotoIAraiSToyoshimaHA case of long-term sildenafil therapy in a young dog with pulmonary hypertensionJ Vet Med Sci200769101073107517984597
- BrownAJDavisonESleeperMMClinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogsJ Vet Intern Med201024485085420412435
- McLaughlinVVPresbergKWDoyleRLPrognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest2004126Suppl 1S78S92
- VitaleCBGrossTLMagroCMVaccine-induced ischemic dermatopathy in the dogVet Dermatol1999102131142
- DouglasWWTazelaarHDHartmanTEPolymyositis-dermatomyositis-associated interstitial lung diseaseAm J Respir Crit Care Med200116471182118511673206
- NagaiSKitaichiMItohHNishimuraKIzumiTColbyTVIdiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOPEur Respir J1998125101010199863989
- BogaardHJAbeKVonk-NoordegraafAVoelkelNFThe right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertensionChest2009135379480419265089
- ArklesJSOpotowskyAROjedaJShape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertensionAm J Respir Crit Care Med2011183226827620709819
- PariautRSaelingerCStricklandKNBeaufrèreHReynoldsCAVilaJTricuspid annular plane systolic excursion (TAPSE) in dogs: reference values and impact of pulmonary hypertensionJ Vet Intern Med20122651148115422860631
- SatoTTsujinoIOhiraHValidation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertensionJ Am Soc Echocardiogr201225328028622230250
- NijveldtRGermansTMcCannGPBeekAMvan RossumACSemi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance studyEur Radiol200818112399240518523785
- DelcroixMVonk-NoordegraafAFadelELangISimonneauGNaeijeRVascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertensionEur Respir J201241122423222903956
- van WolferenSABoonstraAMarcusJTRight ventricular reverse remodelling after sildenafil in pulmonary arterial hypertensionHeart200692121860186117105892
- SchermulyRTKreisselmeierKPGhofraniHAChronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in ratsAm J Respir Crit Care Med20041691394512958054
- XieYPChenBSandersPSildenafil prevents and reverses transverse-tubule remodeling and Ca2+ handling dysfunction in right ventricle failure induced by pulmonary artery hypertensionHypertension201259235536222203744
- TakimotoEChampionHCLiMChronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophyNat Med200511221422215665834